• Tran C, Diorio C, Bérubé S, et al. Relation of insulin-like growth factor (IGF) I and IGF-binding protein 3 concentrations with intakes of fruit, vegetables, and antioxidants. American Journal of Clinical Nutrition, 84(6):1518-1526, Dec 2006
• Travis R, Key T, Allen N et al. Serum androgens and prostate cáncer among 643 cases and 643 controls in the European Prospective Investigation into Cáncer and Nutrition. Int J Cáncer. 2007 May 18 (Epub ahead of print)
• Trichopoulous D et al. Cáncer and Mediterranean dietary traditions. Cáncer Epidemiol Biomarkers Prev 9(9):869-873, Sep 2000
• Trichopoulos D, Li F, Hunter D. What causes cáncer? Sci Am 275(3):80-87,1996.
• Trichopoulos D. Accomplishments and prospects of epidemiology. Prev Med 25:4-6, 1996
• Trump D et al. Androgen Antagonist: Potential role in prostate cáncer prevention. Urology 57 (Suppl 4A): 64-67, 2001
• Tseng M, Breslow R, DeVellis R et al. Dietary patterns and prostate cáncer risk in the National Health and Nutrition Examination Survey Epidemiological Follow-up Study cohort. Cáncer Epidemiol Biomarkers Prev. 13(1):71-77, Jan 2004
• Tyler V. Herbs of choice: the therapeutic use of phytomedicinals New York Pharmac Products Press, 1994
• Tubaro A. Micronutrients and BPH. Eur Urol 50(3):413-415, 2006
• Tubaro A, Montanari E. Management of symptomatic BPH in Italy: who is treated and how? Eur Urol 36(suppl 3):28-32, 1996
• Tuttle-Newhall J, Blackburn G. Cáncer and nutrition: a challenge to the nutritional specialist. In Quillin P, Williams RM editors. Adjuvant Nutrition in Cáncer treatment. Arlington Heights III Cáncer Treatment Research Foundation/American College of Nutrition, 1993
• Turek PJ. Androgens and the aging male): urology.ucsf.edu/patientGuides/ pdf/maleInf/Androgens.pdf
• Urban D et al. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol 165(1):294-300, 2001
• U.S National Institutes of Health, Office of Alternative Medicine. Website www. altmed. od.nih. gov
• Vacherot F, Azzouz M, Gil-Diez-De-Medina S et al. Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasía. Prostate. 45(3):259-266., Nov 1, 2000
• Vaughan D, Imperato-McGinley J, McConnell J, et al. Long term (7 to 8- year) experience with finasteride in men with benign prostatic hyperplasía. Urology 60(6) 1040-1044 Dec 2002.
• Vacherot F, Azzouz M et al. Induction of cell proliferation by the lipido-sterolic extracto of Serenoa repens (LSESr,Permixon®) in benign prostatic hyperplasía. Prostate 45:259-266, 2000
• Vedrine N, Guy L, Manach C. Biovailability of isoflavones in the human prostate. Abstract # 578 Eur Urol Suppl 5(2):167, 2006
• Veltri R, Marks L, Epstein J, Partin A. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism. Urology. 60(4):617-622, Oct 2002
• Venugopal M, et al. Synergistic antitumor activity of vitamin C and K3 against human prostate carcinoma cell lines. Cell Biology International 20:787-797, 1996
• Vickers A. Bibliometric analysis of randomized controlled trials in complementary medicine. Complem Ther Med 6:185-189,1998
• Virtamo J, Edwards B et al. Effects of Supplemental Alpha-Tocopherol and Beta-Carotene (ATBC) on Urinary Tract Cáncer: Incidence and Mortality in a Controlled Trial (Finland) Cáncer Causes-Control 11(10):933-39,Dec 2000
• Vijayababu M, Kanagaraj P et al. Quercetin induces p53-independent apoptosis in human prostate cáncer cells by modulating Bcl-2-related proteins: a possible mediation by IGFBP-3. Oncol Res 16(2):67-74, 2006
• Virchow R. 1863 Cellular Pathology as Based upon Physiological and Pathological Histology. J.B. Lippincott, Philadelphia
• Wagner H et al. Search for the antiprostatic principle of stinging nettle (Urtica dioica) roots. Phytomedicine. 1:213-224, 1994
• Walden P, Globina Y, Nieder A. Induction of anoikis by doxazosin in prostate cáncer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase. Urol Res. 32(4):261-265, Aug 2004
• Walden PD, Gerardi C, Lepor H. Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol. 161(2):635-640, Feb 1999
• Walker A. Vegetable and fruit consumption: Some past, present and future practices. J R Soc Health 115:211-216, 1995
• Walsh PC. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cáncer. J Urol. 173(6):1966-1967, Jun 2005
• Walsh P ,Tempany C , Partin A, Zerhouni E, Zinreich S. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasía The Prostate 22(1):39-42, 1993.
• Wang M, Valenzuela L, et al. Purification of a human prostate-specific antigen. Invest Urol 17;159-163,1979.
• Wang Y, Corr J, Thaler H et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. Journal of the National Cáncer Institute 87(19): 1456-1462, 1995.
• Weinstein M et al. Significance of high grade prostatic intraepithelial neoplasía on needle biopsy.Hum Pathol 24(6):624-629, 1993.
• Welch G, Weinger K, Barry M. Quality-of-life impact of lower urinary tract symptom severity: results from the health professionals follow-up study. Urology 59:245-250,2002
• Wei H, Wei L, Frenkel K et al. Inhibition of Tumor Promoter-induced Hydrogen Peroxide Formation in vitro and in vivo by Genistein. Nutr Cáncer 20(1);1 -12,1993.
• Wheeler R (2007)) Aspectos dieteticos y nutricionales en el cáncer prostático. The Prostatitis & Prostate Cáncer Center Sarasota, Florida http://www. peenuts.com/ article- wheelerdiet.htm
• Wheeler R (2007) Can men with prostate cáncer manage the disease through diet and nutrition while avoiding 'definitive therapy'? The Prostatitis & Prostate Cáncer Center Sarasota, Florida http://www. peenuts. com/ studies- diet andnutrition.htm_
• White J. Complementary, alternative, and unproven methods of cáncer treatment. In: DeVita VT Jr, Hellman S, Rosenberg SA editors. Cáncer: Principles and Practice of Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001, pp 3147-57
• Whittemore A, Kolonel L, Wu A. Prostate cáncer in relation to diet, physical activity and body size in blacks, whites and Asíans in the United States and Canada. J Natl Cáncer Inst. 87(9):652-661, 1995
• Willis M, Wians F.The role of nutrition in preventing prostate cáncer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta. 330(1-2):57-83, April 2003
• Willett W. Health Professionals Follow-up Study: Prospective Studies of Diet and Cáncer in Men and Women. Harvard School of Public Health, Department of Nutrition, Boston, Máss. 2006 National Cáncer Institute (NCI) Epidemiology and Genetics Research http://epi. grants. cáncer.gov/ ResPort/ Health Professionals. html
• Winslow L, Kroll D. Herbs as medicines. Arch Intern Med 158(9):2192-2199,1998
• Wilkinson S et al. Attitudes and use of complementary medicine in men with prostate cáncer. J Urol 168(6):2505-2509 Dec 2002.
• Wilson L, Takao T, Coetzee S et al. The effect of doxazosin on the growth of prostatic tissue in vivo and in vitro. Program Abstracts AUA Annual Meeting J Urol 167(4) Supp Abstracts # 891, April 2002
• Wilson L, Coetzee S, Lepor H et al. Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasía and the effect of doxazosin on tissue size. Prostate. 54(1):17-24, 1 Jan 2003
• Wilt T et al. Chochrane Database Syst Rev 2002; 3: CD001423
• Wilt T et al. Saw Palmetto extracts for treatment of benign prostatic hyperplasía JAMA 280;1604-1609, 1998
• Wilt T, MacDonald R, Ishani A et al. Cernilton for benign prostatic hyperplasía. Cochrane Database Syst Rev. 2000;(2):CD001042.
• Wilt T, MacDonald R, Ishani A. Beta-sitosterol for the treatment of benign prostatic hyperplasía: a systematic review. BJU Int.
• 83:976–983, 1999
• Wilt T, Ishani A, Rutks I et al. Phytotherapy for benign prostatic hyperplasía. Public Health and Nutrition. 3(4A):459-472, 2000
• Willett W, Stampfer M. What vitamins should I be taking, Doctor? NEJM 345(25) Dec 2001
• Willett W, Trichopoulos D. Summary of the evidence: Nutrition and cáncer. Cáncer Causes Control 7:178-180, 1996
• World Cáncer Research Fund/American Institute for Cáncer Research. Food, nutrition and the prevention of cáncer: A global
• perspective. Washington, DC: American Institute for Cáncer Research, 1997.
• Wynder E, Mabuchi K, Whitmore W Jr. Epidemiology of cáncer of the prostate. Cáncer 28(2): 344-360, 1971
• Wynder E et al.Correlating nutrition to recent cáncer mortality statistics. Journal of the National Cáncer Institute 89(4): 324,1997. Wu A, Whitmore A et al.: Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asían men in the United States and Canada. Cáncer Epidemiology, Biomarkers and Prevention 4(7): 735-741, 1995
• Wu K, Erdman J Jr, Willett W, Giovannucci E et al. Plasma and dietary carotenoids, and the risk of prostate cáncer: A nested case-control study. Cáncer Epidemiol Biomarkers Prev 13:260-269, 2004
• Wu D, Lubeck D, Grossfeld G et al. Complementary and alternative medicine. Ch 25:329-338 in Atlas of Clinical Oncology Prostate
• Cáncer Carroll P, Grossfeld G. BC Decker Inc 2002.
• Wu K, Giovannucci E et al.Dietary patterns and risk of prostate cáncer in U.S. men. Canc Epid Biom Prev. 15(1):167-71, Jan 2006 Yang G, Wheeler T, Thompson I. Elevated Caveolin-1 Levels in African-American versus White-American Prostate Cáncer. Clinical
• Cáncer Research 6 (1), 3430-3433, September 2000
• Yatani R. Trends in frecuency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986 JNC Inst 80(9):683-87, 1988
• Yip I et al. Nutrition adjuvant therapy for treatment of prostate cáncer. Experim Biology. In press 1998-1999.
• Yip I, Heber D, Aronson W. Nutrition and prostate cáncer. Urol Clin North Am. 26(2):403-411, May 1999
• Yoshizawa K, Willett W, Morris S, Stampfer M, Spiegelman D, Rimm E, Giovannucci E Study of prediagnostic selenium level in
• toenails and the risk of advanced prostate cáncer.J Natl Cáncer Inst 90:1219-1224,1998
• Yoshimura Y, Yamaguchi O, Bellamy F et al. Effect of Pygeum africanum Tadenan® on micturition and prostate growth of the rat,